Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microban International is a global leader in antimicrobial and odor control technologies, specializing in the development of protective additives for consumer, industrial, and medical products. The company engineers a diverse portfolio of chemistries, including silver-based, zinc-based, and organic technologies, which are integrated into products during the manufacturing process to inhibit the growth of bacteria, mold, and mildew. In the healthcare sector, Microban's solutions are utilized in medical devices, hospital equipment, and high-touch surfaces to enhance hygiene and support infection control protocols. Headquartered in North Carolina, the company operates as a subsidiary of W.M. Barr & Company and maintains partnerships with over 250 manufacturers worldwide. Their technologies are designed to provide continuous, long-lasting surface protection that complements existing cleaning routines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microban International.